Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40.
Cancer Gene Ther. 2020 Dec;27(12):948-959. doi: 10.1038/s41417-020-0176-9. Epub 2020 May 1.
Cancer Gene Ther. 2020.
PMID: 32355275
Free PMC article.